Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101)

Condition:   Aspergillosis
Interventions:   Drug: Posaconazole;   Drug: Voriconazole
Sponsor:   Merck Sharp & Dohme Corp.
Completed